Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06169332
Status:
COMPLETED
Last Update Posted:
2023-12-13
First Post:
2023-11-29
Brief Title:
Multidetector CT Left Appendage Atrial Thrombosis Exclusion in Patients With Atrial Fibrillation
Sponsor:
IRCCS San Raffaele
Organization:
IRCCS San Raffaele
Study Overview
Official Title:
Multidetector CT Left Appendage Atrial Thrombosis Exclusion in Patients With Atrial Fibrillation
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the LATE multidetector CT Lefi Appendage atrial Thrombosis Exclusion in patients with atrial fibrillation study is to evaluate the diagnostic accuracy of cardiac Computed Tomography TC with 64 detectors and double acquisition phase in candidate patients ablation of atrial fibrillation AF with the Navx or Carto technique using trans-esophageal ultrasound TEE as the standard reference
This study is based on the use of an experimental protocol in cardiac TC which involves in addition to the acquisition of an early arterial phase standard protocol routinely performed in all patients the execution of a possible late phase at a very low dose of radiation experimental protocol aimed at increasing the accuracy of the method in the diagnosis in patients with AF The LATE study aims to demonstrate the high diagnostic accuracy of dual acquisition phase cardiac TC in the diagnosis of intraauricular thrombosis by comparing it with reference standard in light of this result cardiac TC could constitute a single non-invasive diagnostic tool in the future for the global evaluation of both atrial anatomy and endoawicular thrombosis with a clear improvement in patient management both in clinical and economic terms
This study is based on the use of an experimental protocol in cardiac TC which involves in addition to the acquisition of an early arterial phase standard protocol routinely performed in all patients the execution of a possible late phase at a very low dose of radiation experimental protocol aimed at increasing the accuracy of the method in the diagnosis in patients with AF The LATE study aims to demonstrate the high diagnostic accuracy of dual acquisition phase cardiac TC in the diagnosis of intraauricular thrombosis by comparing it with reference standard in light of this result cardiac TC could constitute a single non-invasive diagnostic tool in the future for the global evaluation of both atrial anatomy and endoawicular thrombosis with a clear improvement in patient management both in clinical and economic terms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None